$GSK,...Glaxo shareholders vote on Novartis deal on December 18
On December 18 GlaxoSmithKline (NYSE:GSK) shareholders will vote on the company's planned acquisition of Novartis' (NYSE:NVS) vaccines business, the latter's acquisition of Glaxo's cancer products and the combination of their consumer healthcare businesses.
The total value of the assets involved is ~$20B.
invest at your own risk, based on your own due diligence, at your own risk tolerance